PD Therapeutics Market Potential Reviewed in New GlobalData Research Study Published at MarketPublishers.com

Share Article

New research study “Parkinson's Disease Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020” developed by GlobalData has been recently published by Market Publishers Ltd. The study states that posting a CAGR of 5.8% from 2002 to 2011, the global Parkinson’s disease therapeutics market was worth USD 2,992 million last year.

TD The Market Publishers Ltd

http://marketpublishers.com/

Posting a CAGR of 5.8% from 2002 to 2011, the global Parkinson’s disease (PD) therapeutics market was worth USD 2,992 million last year. The market size was chiefly driven by two the increase in PD prevalence due to the rise in the aging population in the eleven key markets and the surging cost of therapy.

By 2020, the worldwide PD therapeutics market is forecast to reach USD 3,650 million growing at a CAGR of 2.2%, with the modest growth rate attributed to patent expiries of the major drugs, the subsequent entry of generics and the weak late-stage developmental pipeline. The major drugs, which are expected go off patent during the forecast period are Azilect, Comtan, Stalevo, Tasmar, Mirapex ER and Requip XL, of which the impact is expected to be partially adjusted by the introduction of new drugs such as IPX 066, preladenant and safinamide during 2011-2020.

New research study “Parkinson's Disease Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020” developed by GlobalData has been recently published by Market Publishers Ltd.

Report Details:

Title: Parkinson's Disease Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020
Published: January, 2012
Pages: 318
Price: US$ 6,995
http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/healthcare_equipment_services/parkinsons_disease_therapeutics_global_drug_forecasts_n_treatment_analysis_to_2020.html

The report delves into extensive research and analysis of the global Parkinson’s disease therapeutics market. It highlights the treatment guidelines and identifies the key trends shaping and driving the market globally; analyzes treatment usage patterns and provides insights into the competitive landscape and the emerging players expected to significantly alter the positions of the market leaders. Furthermore, the study provides valuable insights into the pipeline products and quantifies the unmet need within the worldwide PD therapeutics market as well as in the individual markets of the US and the top five countries in Europe, highlighting opportunities for future players.

Key geographies covered include: the US, the UK, Italy, Spain, Germany, France, Japan, Brazil, Russia, India, and China.

Key future market players mentioned are: Merck & Co, Impax Laboratories, Acadia Pharmaceuticals, Newron Pharmaceuticals, and Abbott Laboratories.

Report Contents:

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Parkinson’s Disease Therapeutics - Disease Overview

2.1 Overview
2.2 Epidemiology
2.3 Etiology
2.3.1 Genetic Factors
2.3.2 Environmental Factors
2.4 Pathophysiology of Parkinson’s Disease
2.5 Symptoms
2.5.1 Primary Motor Symptoms
2.5.2 Secondary Motor Symptoms
2.5.3 Non Motor Symptoms
2.6 Risk Factors
2.7 Prognosis
2.8 Diagnosis
2.8.1 Medical History/Clinical and Neurological Examination
2.8.2 Imaging Techniques
2.9 Treatment
2.9.1 Drug Therapy
2.9.2 Surgery
2.9.3 Rehabilitation Therapy

3 Parkinson’s Disease Therapeutics - Market Characterization

3.1 Global
3.1.1 Market Size
3.1.2 Drivers and Barriers
3.1.3 Forecasts
3.1.4 Drug Sales
3.2 The US
3.2.1 Market Size
3.2.2 Drivers and Barriers
3.2.3 Forecasts
3.2.4 Drug Sales
3.2.5 Pricing and Reimbursements
3.3 The UK
3.3.1 Market Size
3.3.2 Drivers and Barriers
3.3.3 Impact on the Market
3.3.4 Forecasts
3.3.5 Drug Sales
3.3.6 Pricing and Reimbursements
3.4 Germany
3.4.1 Market Size
3.4.2 Drivers and Barriers
3.4.3 Impact on the Market
3.4.4 Forecasts
3.4.5 Drug Sales
3.4.6 Pricing and Reimbursements
3.5 France
3.5.1 Market Size
3.5.2 Drivers and Barriers
3.5.3 Impact on the Market
3.5.4 Forecasts
3.5.5 Drug Sales
3.5.6 Pricing & Reimbursements
3.6 Italy
3.6.1 Market Size
3.6.2 Drivers and Barriers
3.6.3 Impact on the Market
...

More new market research reports by the publisher can be found at GlobalData page.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tanya Rezler
Visit website